Evolent Health EBITDA 2014-2025 | EVH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Evolent Health ebitda from 2014 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Evolent Health ebitda from 2014 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$45.2B
Doximity (DOCS)	$11.6B
Hims & Hers Health (HIMS)	$11.2B
Tempus AI (TEM)	$10.5B
IRhythm Technologies (IRTC)	$4.3B
Inspire Medical Systems (INSP)	$3.8B
Hinge Health (HNGE)	$3.6B
Privia Health (PRVA)	$2.5B
Enovis (ENOV)	$1.8B
Schrodinger (SDGR)	$1.6B
Phreesia (PHR)	$1.5B
10x Genomics (TXG)	$1.5B
Clover Health Investments (CLOV)	$1.5B
Azenta (AZTA)	$1.5B
Omnicell (OMCL)	$1.3B
Claritev (CTEV)	$733M
Fulgent Genetics (FLGT)	$552M
Veradigm (MDRX)	$531M
Standard BioTools (LAB)	$475M
Butterfly Network (BFLY)	$457M
Talkspace (TALK)	$422M
TruBridge (TBRG)	$328M
Outset Medical (OM)	$312M
Nyxoah SA (NYXH)	$282M
Health Catalyst (HCAT)	$261M
SOPHiA GENETICS SA (SOPH)	$250M
CapsoVision (CV)	$218M
Zepp Health (ZEPP)	$206M
KORU Medical Systems (KRMD)	$152M
American Well (AMWL)	$126M